Key result
Compared with FDG-PET as a reference, CMR oedema imaging had low sensitivity and 77% specificity for detecting myocardial inflammation in patients with cardiac sarcoidosis.
Why the study?
Cardiac sarcoidosis can present with cardiac arrest or life-threatening arrhythmias, but data on advanced imaging patterns in this subgroup are limited.
What are the advanced imaging patterns on CMR and FDG-PET in patients with cardiac sarcoidosis presenting with cardiac arrest or life-threatening arrhythmias?
Observational (n=60)
No
What are the advanced imaging patterns on CMR and FDG-PET in patients with cardiac sarcoidosis presenting with cardiac arrest or life-threatening arrhythmias?
In patients with cardiac sarcoidosis presenting with life-threatening arrhythmias, LGE frequently involves the basal anteroseptum and RV side of the septum, and FDG-PET is more sensitive than CMR for detecting myocardial inflammation.
Answers are grounded in this paper and cite their sources.
Variable CMR/PET patterns in CS arrest highlight diagnostic uncertainty; leaves open prospective validation of criteria.
OBJECTIVE: Cardiac sarcoidosis (CS) may present with cardiac arrest or life-threatening arrhythmias. There are limited data on this subgroup of patients with CS. Advanced imaging including cardiovascular magnetic resonance (CMR) and cardiac 18-fluorodeoxyglucose (FDG) positron emission tomography (PET) are used for diagnosis. This study aimed to describe advanced imaging patterns suggestive of CS among patients presenting with cardiac arrest or life-threatening arrhythmias. METHODS: An imaging database of a CS referral centre (Royal Brompton Hospital, London) was screened for patients presenting with cardiac arrest or life-threatening arrhythmias and having imaging features of suspected CS. Patients diagnosed with definite or probable/possible CS were included. RESULTS: Study population included 60 patients (median age 49 years) with male predominance (76.7%). The left ventricle was usually non-dilated with mildly reduced ejection fraction (53.4±14.8%). CMR studies showed extensive late gadolinium enhancement (LGE) with 5 (4-8) myocardial segments per patient affected; the right ventricular (RV) side of the septum (28/45) and basal anteroseptum (28/45) were most frequently involved. Myocardial inflammation by FDG-PET was detected in 45 out of 58 patients vs 11 out of 33 patients with oedema imaging available on CMR. When PET was treated as reference to detect myocardial inflammation, CMR oedema imaging was 33.3% sensitive and 77% specific. CONCLUSIONS: In patients with CS presenting with cardiac arrest or life-threatening arrhythmias, LGE was located in areas where the cardiac conduction system travels (basal anteroseptal wall and RV side of the septum). While CMR was the imaging technique that raised possibility of cardiac scarring, oedema imaging had low sensitivity to detect myocardial inflammation compared with FDG-PET.
No takes yet. Share an insight, caveat, or question.
Hatipoğlu et al. (2023) conducted an observational in Cardiac sarcoidosis presenting with cardiac arrest or life-threatening arrhythmias (n=60). Cardiovascular magnetic resonance (CMR) oedema imaging vs. 18-fluorodeoxyglucose (FDG) positron emission tomography (PET) was evaluated on Detection of myocardial inflammation. Compared with FDG-PET as a reference, CMR oedema imaging had low sensitivity and 77% specificity for detecting myocardial inflammation in patients with cardiac sarcoidosis.
Synapse has enriched 10 related papers. Consider them for comparative context: